Drug and Therapeutics Bulletin 1996;34:89-93; doi:10.1136/dtb.1996.341289
Copyright © 1996 by the BMJ Publishing Group Ltd.

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

Management of hyperlipidaemia

Relevant BNF section: 2.12

The concentrations of lipids in the blood correlate with the risk of developing and dying from illness associated with atheroma such as coronary heart disease (CHD). However, many other factors also affect such risk. So, while therapy that lowers lipid levels can improve outcome, this cannot necessarily be expected for all people treated. At the same time, many individuals who would probably be helped by lipid-lowering treatment do not receive it.¹ Here we discuss the relationship between blood lipid concentrations and CHD, and management strategies for hyperlipidaemia, concentrating on primary and secondary prevention of CHD in adults.

This article has been cited by other articles:

				W S. A Smellie, R. Lowrie, and E. Wilkinson Quality improvement report: A laboratory based intervention to improve appropriateness of lipid tests and audit cholesterol lowering in primary care BMJ, November 24, 2001; 323(7323): 1224 - 1227. [Abstract] [Full Text] [PDF]

				A F Jones, J Walker, C Jewkes, F L Game, W A Bartlett, T Marshall, and G R Bayly Comparative accuracy of cardiovascular risk prediction methods in primary care patients Heart, January 1, 2001; 85(1): 37 - 43. [Abstract] [Full Text]

				R D SITUNAYAKE and G KITAS Dyslipidaemia and rheumatoid arthritis Ann Rheum Dis, June 1, 1997; 56(6): 341 - 342. [Full Text]